Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
67.71
-0.13 (-0.19%)
May 30, 2025, 4:00 PM - Market closed

Haemonetics Stock Forecast

Stock Price Forecast

According to 9 professional analysts, the 12-month price target for Haemonetics stock ranges from a low of $84 to a high of $116. The average analyst price target of $99.78 forecasts a 47.36% increase in the stock price over the next year.

Price Target: $99.78 (+47.36%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $84 $99.78 $100 $116
Change +24.06% +47.36% +47.69% +71.32%

Analyst Ratings

The average analyst rating for Haemonetics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '24Jan '25Feb '25Mar '25Apr '25May '25
Strong Buy 444444
Buy 333333
Hold 222222
Sell 000000
Strong Sell 000000
Total 999999

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
JMP Securities
JMP Securities
Buy
Reiterates
$100
Buy Reiterates $100 +47.69% May 20, 2025
Raymond James
Raymond James
Strong Buy
Reiterates
$115$105
Strong Buy Reiterates $115$105 +55.07% May 9, 2025
Needham
Needham
Strong Buy
Maintains
$104$84
Strong Buy Maintains $104$84 +24.06% May 8, 2025
Needham
Needham
Strong Buy
Maintains
$108$104
Strong Buy Maintains $108$104 +53.60% Mar 18, 2025
Raymond James
Raymond James
Strong Buy
Reiterates
$120$115
Strong Buy Reiterates $120$115 +69.84% Feb 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
1.33B
from 1.36B
Decreased by -2.12%
Revenue Next Year
1.42B
from 1.33B
Increased by 6.76%
EPS This Year
4.94
from 3.31
Increased by 49.38%
EPS Next Year
5.71
from 4.94
Increased by 15.48%
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028
Period Ending Apr 3, 2021 Apr 2, 2022 Apr 1, 2023 Mar 30, 2024 Mar 29, 2025 Mar 31, 2026 Mar 31, 2027 Mar 31, 2028
Revenue
870.46M993.20M1.17B1.31B1.36B1.33B1.42B1.58B
Revenue Growth
-11.94%14.10%17.67%12.01%3.96%-2.12%6.76%10.90%
EPS
1.550.842.242.293.314.945.716.39
EPS Growth
4.73%-45.81%166.67%2.23%44.54%49.38%15.48%11.86%
Forward PE
-----13.6911.8610.60
No. Analysts
-----1194
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High 1.5B 1.6B 1.7B
Avg 1.3B 1.4B 1.6B
Low 1.3B 1.3B 1.5B

Revenue Growth

Revenue Growth 202620272028
High
7.5%
16.5%
21.5%
Avg
-2.1%
6.8%
10.9%
Low
-7.0%
1.3%
3.9%

EPS Forecast

EPS 202620272028
High 5.35 6.14 6.86
Avg 4.94 5.71 6.39
Low 4.71 5.29 5.90

EPS Growth

EPS Growth 202620272028
High
61.8%
24.2%
20.1%
Avg
49.4%
15.5%
11.9%
Low
42.3%
7.0%
3.3%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.